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Introduction  
• Mechanical endovascular reperfusion therapy (MER) is now the standard of  
care for treatment of  large vessel occlusion (LVO) acute ischemic stroke. 

• Nearly 25% of  all stroke patients have a recurrent event within 5 years.
But what about recurrent LVO ?
• In 2017 Bosulma et.al studied 697 patients who underwent endovascular, Fifteen 
(2%) of  treatment for acute ischemic stroke (AIS) over the study period were 
treated with RT. 
• Successful reperfusion was achieved in 14/15 patients after the first thrombectomy 
and in all patients after RT. 
• No parenchymal hemorrhage was observed after the first procedure and two were 
noted after the repeated intervention. 
• The rate of  good clinical outcome at 90 days in RT patients was 60% and their 90-
day mortality rate was only 20%
Methods: 
• We conducted case series study of  Henry ford health system endovascular 
database for patients who underwent RT  from March 2016 till March 2018. 
• Demographic data, clinical presentation, imaging, procedural data and clinical 
outcomes were evaluated.
Results: 
• Of  the total 145 patients with AIS that received MER, 8 (5.5%) RT occurred 
in 5 patients. 
• Mean age was 67 ± 21 years. Four of  the five patients were females. 
• All five patients achieved successful reperfusion (TICI 2b-3). 
• Three patients underwent one RT, one had two RT, and one had three RT. 
• Cardio-embolic source (80%) was the most common etiology and ESUS 
etiology was (20%). 
Results cont.
• The time between the first to last MER for each patient ranged from 3 days to 2 years. 
• All patients were optimized on their medical therapy after the first stroke.
• Four of  the five patients (80%) had RT in the same vascular territory.
• One patient had post-procedure focal high-grade stenosis after the 3rd intervention in the same 
artery that was treated later with elective angioplasty. 
• One RT was complicated with fatal intracranial hemorrhage due to late presentation despite 
presence of  large area of  penumbra. 
• Average 3 months follow up MRS was 2. 

Conclusion: 
• In patients presented with recurrent LVO, RT appears to be effective and relatively 
safe. Based on the available literature, prior MER should not discourage aggressive 
treatment that may potentially lead to a good clinical outcome. 
• It is unclear if  prior MER therapies cause endothelial injury leading to a predilection 
for local in-situ thrombus or denovo stenosis formation predisposing to re-
occlusions. 
• The risk of  reperfusion injury in a recently infarcted territory should be weighted 
carefully when considering as hemorrhagic complications remain possible.
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